Use of metformin and risk of kidney cancer in patients with type 2 diabetes

European Journal of Cancer

Volumn 52, Issue , 2016, Pages 19-25

  Tseng, Chin Hsiao ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Diabetes; Epidemiology; Kidney cancer; Metformin; Taiwan

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEGLITINIDE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIOGLITAZONE; ROSIGLITAZONE; SULFONYLUREA; TICLOPIDINE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TAIWAN; TREATMENT DURATION; TREATMENT INDICATION; DIABETES MELLITUS, TYPE 2; FACTUAL DATABASE; INCIDENCE; KIDNEY NEOPLASMS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; PROTECTION; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

ADULT; AGED; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; KIDNEY NEOPLASMS; MALE; METFORMIN; MIDDLE AGED; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; TAIWAN; TIME FACTORS;

EID: 84948447754     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.09.027     Document Type: Article

References (37)

1. W.H. Chow, L.M. Dong, and S.S. Devesa Epidemiology and risk factors for kidney cancer Nat Rev Urol 7 2010 245 257
2. H.B. Guan, Q.J. Wu, and T.T. Gong Parity and kidney cancer risk: evidence from epidemiologic studies Cancer Epidemiol Biomarkers Prev 22 2013 2345 2353
3. E. Cho, H.O. Adami, and P. Lindblad Epidemiology of renal cell cancer Hematol Oncol Clin North Am 25 2011 651 665
4. S.W. Lai, K.F. Liao, H.C. Lai, P.Y. Tsai, F.C. Sung, and P.C. Chen Kidney cancer and diabetes mellitus: a population-based case-control study in Taiwan Ann Acad Med Singap 42 2013 120 124
5. Bureau of Health Promotion Cancer registry annual report 2008 2010 Department of Health, Executive Yuan Taiwan http://www.hpa.gov.tw/DOWNLOAD/Statistics/1.%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%B9%B4%E5%BA%A6%E5%A0%B1%E5%91%8A%EF%BC%88%E5%85%A8%EF%BC%89(92%E5%B9%B4%E4%BB%A5%E5%BE%8C%E8%B3%87%E6%96%99%E5%83%85%E5%90%AB%E4%BE%B5%E8%A5%B2%E7%99%8Chttp://www.hpa.gov.tw/DOWNLOAD/Statistics/1.%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%B9%B4%E5%BA%A6%E5%A0%B1%E5%91%8A%EF%BC%88%E5%85%A8%EF%BC%89(92%E5%B9%B4%E4%BB%A5%E5%BE%8C%E8%B3%87%E6%96%99%E5%83%85%E5%90%AB%E4%BE%B5%E8%A5%B2%E7%99%8C)/Y97-%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%B9%B4%E5%BA%A6%E5%A0%B1%E5%91%8A%EF%BC%88%E5%85%A8).pdf (20 January 2015, date last accessed).
6. C.C. Lin, J.H. Chiang, C.I. Li, C.S. Liu, W.Y. Lin, T.F. Hsieh, and et al. Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan BMC Cancer 14 2014 381
7. P.H. Hung, H.B. Tsai, K.Y. Hung, C.H. Muo, M.C. Chung, C.H. Chang, and et al. Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study Medicine (Baltimore) 93 2014 e52
8. C.J. Chung, C.Y. Huang, H.B. Tsai, C.H. Muo, M.C. Chung, C.H. Chang, and et al. Sex differences in the development of malignancies among end-stage renal disease patients: a nationwide population-based follow-up study in Taiwan PLoS One 7 2012 e44675
9. T.Y. Lee, S.F. Ko, Y.L. Wan, Y.F. Cheng, B.Y. Yang, D.L. Huang, and et al. Renal squamous cell carcinoma: CT findings and clinical significance Abdom Imaging 23 1998 203 208
10. C.C. Yeh, T.H. Lin, H.C. Wu, C.H. Chang, C.C. Chen, and W.C. Chen A high association of upper urinary tract transitional cell carcinoma with nonfunctioning kidney caused by stone disease in Taiwan Urol Int 79 2007 19 23
11. C.H. Tseng Pioglitazone and bladder cancer: a population-based study of Taiwanese Diabetes Care 35 2012 278 280
12. C.H. Tseng A review on thiazolidinediones and bladder cancer in human studies J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 32 2014 1 45
13. C.H. Tseng, K.Y. Lee, and F.H. Tseng An updated review on cancer risk associated with incretin mimetics and enhancers J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 33 2015 67 124
14. C.H. Tseng Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan Eur J Endocrinol 167 2012 409 416
15. C.H. Tseng Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes Acta Diabetol 51 2014 295 303
16. H. Noto, A. Goto, T. Tsujimoto, and M. Noda Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis PLoS One 7 2012 e33411
17. M. Franciosi, G. Lucisano, E. Lapice, G.F. Strippoli, F. Pellegrini, and A. Nicolucci Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review PLoS One 8 2013 e71583
18. A. Ferrara, J.D. Lewis, C.P. Quesenberry Jr., T. Peng, B.L. Strom, S.K. Van Den Eeden, and et al. Cohort study of pioglitazone and cancer incidence in patients with diabetes Diabetes Care 34 2011 923 929
19. P.D. Home, S.E. Kahn, N.P. Jones, D. Noronha, H. Beck-Nielsen, G. Viberti ADOPT Study Group; RECORD Steering Committee Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials Diabetologia 53 2010 1838 1845
20. J. Woodard, S. Joshi, B. Viollet, N. Hay, and L.C. Platanias AMPK as a therapeutic target in renal cell carcinoma Cancer Biol Ther 10 2010 1168 1177
21. G. Rena, E.R. Pearson, and K. Sakamoto Molecular mechanism of action of metformin: old or new insights? Diabetologia 56 2013 1898 1906
22. C.H. Tseng, C.P. Tseng, C.K. Chong, T.P. Huang, Y.M. Song, C.W. Chou, and et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort Diabetologia 49 2006 1755 1760
23. L. Chang A study of validation on comorbidity derived from claims data [Master thesis] 2004 National Yang-Ming University
24. P.C. Austin The performance of different propensity score methods for estimating marginal hazard ratios Stat Med 32 2013 2837 2849
25. M.A. Brookhart, R. Wyss, J.B. Layton, and T. Stürmer Propensity score methods for confounding control in nonexperimental research Circ Cardiovasc Qual Outcomes 6 2013 604 611
26. X.L. Yang, R.C. Ma, W.Y. So, A.P. Kong, G. Xu, and J.C. Chan Addressing different biases in analysing drug use on cancer risk in diabetes in non-clinical trial settings-what, why and how? Diabetes Obes Metab 14 2012 579 585
27. S.K. Pal, and D.I. Quinn Differentiating mTOR inhibitors in renal cell carcinoma Cancer Treat Rev 39 2013 709 719
28. J. Kasznicki, A. Sliwinska, and J. Drzewoski Metformin in cancer prevention and therapy Ann Transl Med 2 2014 57
29. C. Pulito, S. Donzelli, P. Muti, L. Puzzo, S. Strano, and G. Blandino microRNAs and cancer metabolism reprogramming: the paradigm of metformin Ann Transl Med 2 2014 58
30. Z.H. Liu, J. Xie, Y.B. Xiao, Y.Q. Yuan, X.W. Zhang, C.P. Qin, and et al. Free fatty acids induce proliferation of human renal carcinoma 786-O cell line via integrin-linked kinase Beijing Da Xue Xue Bao 45 2013 217 220
31. B. Bao, A.S. Azmi, S. Ali, F. Zaiem, and F.H. Sarkar Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers Ann Transl Med 2 2014 59
32. A. Hambrock, C.B. de Oliveira Franz, S. Hiller, and H. Osswald Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1 (M1289T) J Pharmacol Exp Ther 316 2006 1031 1037
33. A. Hambrock, C.B. de Oliveira Franz, S. Hiller, A. Grenz, S. Ackermann, D.U. Schulze, and et al. Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner J Biol Chem 282 2007 3347 3356
34. W. Chen, T. Seefeldt, A. Young, X. Zhang, and X. Guan Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents Bioorg Med Chem 19 2011 287 294
35. M. Mahjoubi, J. Kattan, M. Bonnay, H. Schmitt, and J.P. Droz Phase II trial of LY 186641 in advanced renal cancer Invest New Drugs 11 1993 323 328
36. M. Washio, M. Mori, K. Mikami, T. Miki, Y. Watanabe, M. Nakao, and et al. Risk factors for renal cell carcinoma in a Japanese population Asian Pac J Cancer Prev 15 2014 9065 9070
37. C.H. Tseng Body mass index and blood pressure in adult type 2 diabetic patients in Taiwan Circ J 71 2007 1749 1754